<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="per this research, chitosan-based nanoparticles in combination with alginate and" exact="folic acid" post="are tremendous vectors for the definite delivery of 5-ALA"/>
 <result pre="fluorescent dye (Cy 5.5) by chemical conjugation, and then, the" exact="irinotecan" post="anticancer drug (IRT) was encapsulated within these systems. The"/>
 <result pre="60] prepared perfluorohexane (PFH) nanodroplets stabilized with alginate to drive" exact="doxorubicin" post="and then evaluated their sensitivity to ultrasound and imaging"/>
 <result pre="found that the ultrasound-facilitated treatment with PFH nanodroplets loaded with" exact="doxorubicin" post="exhibited promising positive responses in the breast cancer rat"/>
 <result pre="an appropriate material for pharmacological application. Also, the polymeric material" exact="dextran" post="is a neutral polymer and is assumed as the"/>
 <result pre="exopolysaccharides used in medical applications. A remarkable advantage of using" exact="dextran" post="is that it is well-tolerated, non-toxic, and biodegradable in"/>
 <result pre="multifunctional composite system by encapsulating Fe 3O 4 nanoparticles in" exact="dextran" post="nanoparticles conjugated to redox-responsive chlorine 6 (C6) for near"/>
 <result pre="particles comprised of gadolinium oxide nanoparticles coated with folic acid-conjugated" exact="dextran" post="(FA) or paclitaxel (PTX). The bioprotective effects of dextran"/>
 <result pre="gadolinium oxide nanoparticles coated with folic acid-conjugated dextran (FA) or" exact="paclitaxel" post="(PTX). The bioprotective effects of dextran coating and the"/>
 <result pre="acid-conjugated dextran (FA) or paclitaxel (PTX). The bioprotective effects of" exact="dextran" post="coating and the chemotherapeutic effect of PTX on the"/>
 <result pre="al. [ 74] designed a crosslinkable lipid shell (CLS) containing" exact="docetaxel" post="and wortmannin as the prototypical drugs used for controlling"/>
 <result pre="the efficacy of a 0.75% w/w isotonic solution of hydroxypropyl" exact="methylcellulose" post="(HPMC) containing chitosan/sodium tripolyphosphate/hyaluronic acid nanoparticles to deliver the"/>
 <result pre="(HPMC) containing chitosan/sodium tripolyphosphate/hyaluronic acid nanoparticles to deliver the antibiotic" exact="ceftazidime" post="to the eye. The rheological synergism parameter was calculated"/>
 <result pre="prepared nanoparticles of carboxymethyl chitosan for the release of intra-nasal" exact="carbamazepine" post="(CBZ) to bypass the blood–brain barrier membrane, thus increasing"/>
 <result pre="Patil and Devarajan [ 119] developed insulin-containing alginate nanoparticles with" exact="nicotinamide" post="as a permeation agent in order to lower the"/>
 <result pre="rats. Nanoparticles administered sublingually (5 IU/kg) in the presence of" exact="nicotinamide" post="showed high availability pharmacology (&amp;gt; 100%) and bioavailability (&amp;gt; 80%). The"/>
 <result pre="Haque et al. [ 120] prepared alginate nanoparticles to release" exact="venlafaxine" post="(VLF) via intranasal for treatment of depression. The higher"/>
 <result pre="123] prepared chitosan-coated alginate nanoparticles to enhance the permeation of" exact="daptomycin" post="into the ocular epithelium aiming for an antibacterial effect."/>
 <result pre="ocular epithelial cell culture models. The antimicrobial activity of nanoencapsulated" exact="daptomycin" post="showed potential over the pathogens engaged in bacterial endophthalmitis."/>
 <result pre="h of treatment from 9 to 12% in total of" exact="daptomycin" post="encapsulated in chitosan/alginate nanoparticles, these were able to cross"/>
 <result pre="was used as a major polymer in which the-((2-amino-2-carboxyethyl) disulfanyl)" exact="nicotinic acid" post="(Cys-MNA) was coupled. Characteristics, such as amount of the"/>
 <result pre="cellulose nanocrystals and chitosan nanoparticles for the oral releasing of" exact="repaglinide" post="(an anti-hyperglycemic—RPG). The chitosan nanoparticles showed a mean size"/>
 <result pre="during liposome formation) approaches [ 135]. Hydrophilic drugs such as" exact="ampicillin" post="and, 5-fluoro-deoxyuridine are typically confined in the aqueous core"/>
 <result pre="147]. In the work by Li et al. [ 148]," exact="dasatinib" post="was encapsulated within nanoparticles prepared from micellation of PEG-b-PC,"/>
 <result pre="that doxorubicin-folate conjugated poly- l-lysine dendrimers increased the concentration of" exact="doxorubicin" post="in the tumor by 121.5-fold after 24 h compared"/>
 <result pre="[ 157] developed folate-conjugated polypropylene imine dendrimers (FA-PPI) as a" exact="methotrexate" post="(MTX) nanocarrier, for pH-sensitive drug release, selective targeting to"/>
 <result pre="it has to be pointed out that the developed formulations," exact="methotrexate" post="(MTX)-loaded and folic acid-conjugated 5.0G PPI (MTX-FA-PPI), were selectively"/>
 <result pre="by the tumor cells in comparison with the free drug," exact="methotrexate" post="(MTX). Inorganic nanoparticles Inorganic nanoparticles include silver, gold, iron"/>
 <result pre="system with covalently attached silver nanoparticles for the release of" exact="ornidazole" post="which turned out to have an in vitro release"/>
 <result pre="system. The nanoparticles were spherical with higher encapsulation efficiency of" exact="paclitaxel" post="(80.7 ± 2.11%) and tumor growth inhibition rate of 77.85%. The"/>
 <result pre="with HA-receptor CD44, respectively. This nanocarrier was also evaluated for" exact="doxorubicin" post="(DOX) sustained release. The nanocarrier was stable in physiological"/>
 <result pre="its analogues derived from the Taxus brevifolia plant; vinblastine and" exact="vincristine" post="extracted from Catharanthus roseus; camptothecin and its analogs derived"/>
 <result pre="[ 205, 206]. This section is focused on berberine, curcumin," exact="ellagic acid," post="resveratrol, curcumin and quercetin [ 8]. Some other compounds"/>
 <result pre="and quercetin [ 8]. Some other compounds mentioned are doxorubicin," exact="paclitaxel" post="and vancomycin that also come from natural products. Nanoparticles"/>
 <result pre="[ 8]. Some other compounds mentioned are doxorubicin, paclitaxel and" exact="vancomycin" post="that also come from natural products. Nanoparticles have been"/>
 <result pre="were performed on rabbits and the results indicated that the" exact="ellagic acid" post="prevented the formation of free oxygen radicals and their"/>
 <result pre="from a number of different wild type strains of Streptomyces," exact="doxorubicin" post="(DOX) is a hydrolated version of it used in"/>
 <result pre="system for intracellular fluorescent imaging and for the delivery of" exact="doxorubicin" post="in which the nanoparticles were functionalized with transferrin. Cellular"/>
 <result pre="intracellular delivery [ 235]. Purama et al. [ 236] extracted" exact="dextran" post="from two sucrose based lactic acid bacteria namely Streptococcus"/>
 <result pre="been used for the delivery of Doxil (a form of" exact="doxorubicin" post="which was the first FDA-approved nano-drug in 1995) ["/>
 <result pre="advantage Indication(s) Year approved Adagen ®/pegademase bovine (Sigma-Tau Pharmaceuticals) PEGylated" exact="adenosine" post="deaminase enzyme Improve circulation time and decreased immunogenicity Severe"/>
 <result pre="®/Glatopa (Teva) Random copolymer of l-glutamate, l alanine, l-lysine and" exact="l-tyrosine" post="Large amino-acid based polymer with controlled molecular weight and"/>
 <result pre="formulations combined with drugs or biologics DaunoXome ® (Galen) Liposomal" exact="daunorubicin" post="Increased delivery to tumour site; lower systemic toxicity arising"/>
 <result pre="toxicity arising from side-effects Karposi’s sarcoma 1995 DepoCyt© (Sigma-Tau) Liposomal" exact="cytarabine" post="Increased delivery to tumour site; lower systemic toxicity arising"/>
 <result pre="from side-effects Lymphomatous meningitis 1996 Marqibo ® (Onco TCS) Liposomal" exact="vincristine" post="Increased delivery to tumour site; lower systemic toxicity arising"/>
 <result pre="from side-effects Acute lymphoblastic leukemia 2012 Onivyde ® (Merrimack) Liposomal" exact="irinotecan" post="Increased delivery to tumour site; lower systemic toxicity arising"/>
 <result pre="release Analgesia (post-operative) 2004 Visudyne ® (Bausch and Lomb) Liposomal" exact="verteporfin" post="Increased delivery to site of diseased vessels; photosensitive release"/>
 <result pre="wet age-related; myopia; ocular histoplasmosis 2000 Doxil ®/Caelyx™ (Janssen) Liposomal" exact="doxorubicin" post="Improved delivery to site of disease; decrease in systemic"/>
 <result pre="respiratory distress syndrome 1999 Vyxeos (Jazz Pharma) Lipossomal combination of" exact="daunorubicin" post="and cytarabine Sustained release of the molecules and co-loaded"/>
 <result pre="syndrome 1999 Vyxeos (Jazz Pharma) Lipossomal combination of daunorubicin and" exact="cytarabine" post="Sustained release of the molecules and co-loaded two molecules"/>
 <result pre="Micellar nanoparticles combined with drugs or biologics Estrasorb™ (Novavax) Micellar" exact="estradiol" post="Controlled delivery of therapeutic Menopausal therapy 2003 Protein nanoparticles"/>
 <result pre="nanoparticles combined with drugs or biologics Abraxane ®/ABI-007 (Celgene) Albumin-bound" exact="paclitaxel" post="nanoparticles Improved solubility; improved delivery to tumor Breast cancer;"/>
 <result pre="chronic kidney disease (CKD) 1999 INFeD ® (Sanofi Avertis) Iron" exact="dextran" post="(low MW) Allows increased dose Iron deficiency in chronic"/>
 <result pre="kidney disease (CKD) 1957 DexIron ®/Dexferrum ® (Sanofi Avertis) Iron" exact="dextran" post="(low MW) Allows increased dose Iron deficiency in chronic"/>
 <result pre="(CKD) 1957 Feridex ®/Endorem ® (AMAG pharmaceuticals) SPION coated with" exact="dextran" post="Superparamagnetic character Imaging agent 1996 (2008) GastroMARK™; umirem ®"/>
 <result pre="decrease toxicity 2015 Adagen ® (Sigma-Tau Pharmaceuticals) Pegademase bovine PEGylated" exact="adenosine" post="deaminase enzyme Immunodeficiency disease Improve circulation time in body"/>
 <result pre="PEGylation 1994 Copaxone ® (Teva) Glatopa l-Glutamate, l-alanine, l-lysine and" exact="l-tyrosine" post="random copolymer Multiple sclerosis Regulation of clearance and polymer"/>
 <result pre="controlled molecular weight 1996 Renagel ® (Sanofi) Sevelamer hydrochloride or" exact="sevelamer" post="carbonate Poly(allylamine hydrochloride) Chronic renal diseases Increase site-specific delivery"/>
 <result pre="therapy Sustained release 2003 Abraxane ® (Celgene) Paclitaxel (ABI-007) Albumin-bound" exact="paclitaxel" post="nanoparticles Breast cancer; non-small cell lung cancer and pancreatic"/>
 <result pre="(tumor) and solubility 2005;2012;2013 INFeD ® (Sanofi Avertis) Iron Iron" exact="dextran" post="(low MW) Chronic kidney failure with iron deficiency Increased"/>
 <result pre="dose capacity 1957 DexIron ®/Dexferrum ® (Sanofi Avertis) Iron Iron" exact="dextran" post="(high MW) Chronic kidney failure with iron deficiency Increased"/>
 <result pre="(AMAG pharmaceuticals) Superparamagnetic iron oxide nanoparticles (SPION) SPION coated with" exact="dextran" post="Imaging material Superparamagnetic character 1996/2008 Ferrlecit ® (Sanofi Avertis)"/>
 <result pre="examples are the therapeutic application of nanotechnology for berberine, curcumin," exact="ellagic acid," post="resveratrol, curcumin and quercetin. The efficacy of these natural"/>
 <result pre="through near-infrared; photodynamic detection of colorectal cancer using alginate and" exact="folic acid" post="based chitosan nanoparticles; utilization of cathepsin B as metastatic"/>
 <result pre="hyaluronic acid as a biopolymeric material in cancer therapy; and" exact="dextran" post="among others. Since the 1990s, the list of FDA-approved"/>
 <result pre="reality. Abbreviations AR Amaranth red CBF ciliary beat frequency CBZ" exact="carbamazepine" post="CC colorectal cancer CMC carboxymethylcellulose Cys-MNA ((2-amino-2-carboxyethyl) disulfanyl) nicotinic"/>
 <result pre="CBZ carbamazepine CC colorectal cancer CMC carboxymethylcellulose Cys-MNA ((2-amino-2-carboxyethyl) disulfanyl)" exact="nicotinic acid" post="(Cys-MNA) EPR penetrability and holding FA folic acid-conjugated dextran"/>
 <result pre="nicotinic acid (Cys-MNA) EPR penetrability and holding FA folic acid-conjugated" exact="dextran" post="FDA Food and Drug Administration FeO ferrous oxide HA"/>
 <result pre="magnetic resonance NIR near infrared NP nanoparticle PFH perfluorohexane PTX" exact="paclitaxel" post="RPG repaglidine VEGF antivascular endothelial growth factor VLF venlafaxine"/>
 <result pre="PTX paclitaxel RPG repaglidine VEGF antivascular endothelial growth factor VLF" exact="venlafaxine" post="XG xanthan gum Authors’ contributions JKP, GD, LFF, EVRC,"/>
 <result pre="E Cattel L Hyaluronic acid-coated liposomes for active targeting of" exact="gemcitabine" post="Eur J Pharm Biopharm 2013 85 373 380 10.1016/j.ejpb.2013.06.003"/>
 <result pre="G Wu Y Zhang P Ling S Cai L Redox-responsive" exact="dextran" post="based theranostic nanoparticles for near-infrared/magnetic resonance imaging and magnetically"/>
 <result pre="Shen Q Hyaluronic acid-coated cationic nanostructured lipid carriers for oral" exact="vincristine" post="sulfate delivery Drug Dev Ind Pharm 2017 43 661"/>
 <result pre="2014 2014 926157 25101184 119. Patil NH Devarajan PV Insulin-loaded" exact="alginic acid" post="nanoparticles for sublingual delivery Drug Deliv 2016 23 429"/>
 <result pre="Pintado M Potential chitosan-coated alginate nanoparticles for ocular delivery of" exact="daptomycin" post="Eur J Clin Microbiol Infect Dis 2015 34 1255"/>
 <result pre="nanocomposites as a carrier system for the controlled release of" exact="repaglinide" post="Int J Biol Macromol. 2018 111 604 613 10.1016/j.ijbiomac.2018.01.044"/>
 <result pre="KK Choi CHJ Gao QY Lee TW Micellar delivery of" exact="dasatinib" post="for the inhibition of pathologic cellular processes of the"/>
 <result pre="J Selotlegeng L Zhang N Near-infrared mediated quantum dots and" exact="paclitaxel" post="co-loaded nanostructured lipid carriers for cancer theragnostic Coll Surf"/>
 <result pre="W Pan H The reversion of anti-cancer drug antagonism of" exact="tamoxifen" post="and docetaxel by the hyaluronic acid-decorated polymeric nanoparticles Pharmacol"/>
 <result pre="H The reversion of anti-cancer drug antagonism of tamoxifen and" exact="docetaxel" post="by the hyaluronic acid-decorated polymeric nanoparticles Pharmacol Res 2017"/>
 <result pre="Chourasia MK Kumar V Enhanced apoptotic and anticancer potential of" exact="paclitaxel" post="loaded biodegradable nanoparticles based on chitosan Int J Biol"/>
 <result pre="P Khan AT Goyal A Structural analysis and properties of" exact="dextran" post="produced by Leuconostoc mesenteroides NRRL B-640 Carbohydr Polym 2009"/>
 <result pre="S Jeon Y-S Shim C-K Kim W Kim J Multifunctional" exact="doxorubicin" post="loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic"/>
</results>
